Hap Trading, LLC Corbus Pharmaceuticals Holdings, Inc. Put Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$0.6 - $1.11 $3,120 - $5,772	5,200 Added 51.49%	15,300 $25,000
Q3 2021 Nov 10, 2021	SELL	$1.01 - $1.82 $3,434 - $6,188	-3,400 Reduced 25.19%	10,100 $21,000
Q2 2021 Aug 11, 2021	SELL	$1.39 - $2.21 $24,603 - $39,117	-17,700 Reduced 56.73%	13,500 $16,000
Q1 2021 May 14, 2021	BUY	$1.27 - $3.42 $17,526 - $47,196	13,800 Added 79.31%	31,200 $32,000
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $2,820 - $5,670	-3,000 Reduced 14.71%	17,400 $30,000
Q3 2020 Nov 13, 2020	BUY	$1.5 - $9.38 $30,600 - $191,352	20,400 New	20,400 $37,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.62B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.